Riskpilot← Back to searchSign inGet full accessPersMedic Aktiebolag
ABActiveOrg 5569129165Bondsättersvägen 81Medical specialists activities · NACE 8622Est. 20121 employees
Revenue 2025
SEK 222K
-61% vs 2024
EBITDA margin
-79.4%
-274% vs 2024
Equity ratio
88.0%
Financial strength
Net profit 2025
SEK 12K
-91% vs 2024
| Revenue | SEK 222K | -61% |
| EBITDA | SEK -177K | -274% |
| Net profit | SEK 12K | -91% |
| Total assets | SEK 1,1M | -17% |
| Equity | SEK 947K | +1% |
| Employees | 1 | — |
Legal name
PersMedic Aktiebolag
Org number
5569129165
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
4 december 2012
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Hälso- och sjukvårdsverksamhet. Läkarpraktik samt därmed förenlig verksamhet. Konsulttjänster inom det medicinska området. Handel med medicinteknisk utrustning. Personalkonsultverksamhet. Redovisningstjänster. Fastighetsförvaltning.
Address
Bondsättersvägen 81
Email
p-m@drstenlund.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 776 | 626 | 372 | 570 | 222 |
| Staff expenses | — | −69 | −52 | −64 | −66 |
| EBITDA | 380 | 231 | −72 | 102 | −177 |
| Depreciation & amort. | −8 | — | — | — | — |
| EBIT | 372 | 231 | −72 | 102 | −177 |
| Net financials | −1 | −1 | −1 | 29 | 46 |
| Profit before tax | 464 | 434 | 111 | 180 | 20 |
| Tax | −103 | −96 | −28 | −45 | −8 |
| Net profit | 361 | 338 | 83 | 135 | 12 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 728 | 1 603 | 1 444 | 1 292 | 1 076 |
| Equity | 945 | 912 | 995 | 935 | 947 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 124 | 236 | 177 | 135 | 57 |
| Total debt | 124 | 236 | 177 | 135 | 57 |
EBITDA margin
-79.4%
This company
15.8%
Market median
-603% vs market
20212025
Equity ratio
88.0%
This company
38.2%
Market median
+130% vs market
20212025
Return on equity
1.3%
This company
18.4%
Market median
-93% vs market
20212025
Net profit margin
5.3%
This company
8.1%
Market median
-35% vs market
20212025
Asset turnover
0.21×
This company
1.12×
Market median
-81% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PS Chief Executive Officer | Chief Executive Officer | 2020 |
MA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2020 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of PersMedic Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per-Mårten Stenlund | Chief Executive Officer | 0 companies |
| Merja Anneli Luuk Stenlund | Deputy Chief Executive Officer | 0 companies |